Herantis Pharma Oyj (HRTIS) — Long-term Investment Intensity

Latest as of June 2018: 0.0%

Herantis Pharma Oyj (HRTIS) has a Long-term Investment Intensity of 0.0% as of June 2018. Long-term investments of €1.16K represent 0.0% of total assets of €9.42 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Herantis Pharma Oyj (HRTIS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.0%
LT Investments / Total Assets

Long-term Investments

€1.16K
EUR

Total Assets

€9.42 Million
EUR

Country

Finland
HE

Herantis Pharma Oyj Long-term Investment Intensity (2014–2017)

This chart shows how Herantis Pharma Oyj's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2017. As of June 2018, the intensity stands at 0.0%, reflecting long-term investments of €1.16K against total assets of €9.42 Million EUR. Explore Herantis Pharma Oyj cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Herantis Pharma Oyj (2014–2017)

The table below presents the year-by-year Long-term Investment Intensity for Herantis Pharma Oyj from 2014 to 2017, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see HRTIS company net worth.

Year LT Investment Intensity LT Investments (EUR) Total Assets Change (pp)
2017 0.0% €1.16K €11.57 Million ▼ 0.0 pp
2016 0.0% €1.16K €10.21 Million ▲ +0.0 pp
2015 0.0% €1.16K €14.09 Million ▲ +0.0 pp
2014 0.0% €1.16K €29.49 Million
pp = percentage points